Abstract⎯For a long time people are using plants not only as crop cultures but also for obtaining of various chemicals. Currently plants remain one of the most important and essential sources of biologically active compounds in spite of progress in chemical or microbial synthesis. In our review we compare potentials and perspectives of modern genetic engineering approaches for pharmaceutical biotechnology and give examples of actual biotechnological systems used for production of several promising natural compounds: artemisinin, paclitaxel and scopolamine.
INTRODUCTION
One of the most important tasks for modern genetic engineering, biotechnology and pharmacol ogy is search or creation of systems for high scale obtaining of valuable natural products -complex organic compounds produced by living organisms. Since the earliest time people used plants not merely as food crops but additionally as sources of various chemicals: pharmaceuticals, insecticides, food sup plements, dyes etc. Currently plants remain an essen tial provider of biologically active compounds in spite of development of chemical or microbial technologies. A number of inherent advantages make plants the cen tral and highly perspective object in natural product biosynthesis researches e.g. (a) ecological and phar macological safety; (b) high native biosynthetic capa bilities including multistep stereospecific synthesis of complex organic molecules, eukaryotic type of biopolymer synthesis and processing; (c) possibilities of scaling up of valuable compound production using natural potential of plant systems; and (d) economical values.
For primary classification of pharmacologically valuable plant natural substances one can define a group of mainly low molecular weight compounds, including first of all plant secondary metabolites, and a group of proteins and peptides with high molecular weight which are the products of heterological expres sion of foreign genes in plant cells.
All biochemical processes in plant cell can be condi tionally classified as primary and secondary metabo lism. Compounds and processes which are necessary for growth, development and breeding belong to primary metabolism. It includes mainly the metabolism of pro teins, nucleic acids, carbohydrates and lipids. On the 1 The article is published in the original.
other hand, biosynthesis and catabolism of variable pig ments, alkaloids, terpenes, phenolics belong to second ary metabolism. All these substances considered to be not directly essential for plant cell life, and their func tion in plants is not always clear [1, 2] . The majority of secondary compounds are considered to be participat ing in plant environment interactions: they defense plants from pathogens, pests or herbivores, serve as attractants, have allelopathic, photo protective or light harvesting functions [1] [2] [3] [4] . It is not surprising that most of them have a strong influence upon animal and human organism. Numerous examples of pharmaceuti cal applications of plant secondary metabolites are given in recent reviews [5] [6] [7] [8] [9] .
People studied pharmacological properties of sec ondary compounds since great antiquity: mentions of medicinal applications of alkaloid containing plant were found among Chinese, Mesopotamia and, later, India ancient sources dated 3000-1000 B. C. [10] . Organic synthesis progress at the close of the 19 cen tury and development of chromatographic separation protocols in the first half of the 20 century allowed iso lation and identification of numerous organic sub stances responsible for pharmacological activities of plant extracts. However, in spite of considerable suc cess in modern organic synthesis, plants' ability to form biologically active stereoisomers often makes them the unique and essential source of pharmacolog ically valuable natural products. Moreover, consider able part of synthetic pharmaceuticals has been devel oped as modifications of natural substances of plant origin. As the experts estimate, in USA nearly 50% of drugs for cancer chemotherapy are derivatives of plant extract components [11] . One should remark that searching of the optimal balance between drug effi ciency and toxicity in the recent years brought scien tists again to substances isolated from natural sources, first of all from plants [12] .
In recent years an intensive work has been carried out on screening of biological activity and structural diversity of secondary metabolites. Nevertheless the biosynthetic potential of plant cells is considered to be not even half exhausted a total amount of substances produced by plants was estimated in range about 500 thousands [13, 14] . Actual models suggest correla tion between evolution of secondary metabolism in plants and reciprocal adaptation of pests or pathogens leading to divergence and stimulating biodiversity in the both groups [1] .
The majority of secondary biosynthetic pathways are multistep enzymatic processes with complex and delicate regulation mechanisms on transcriptional and/or posttranscriptional level. Segregation of inter mediates inside of single plant cell or their transport between different parts of the whole plant often occurs. All these factors make investigation and, espe cially, controlled biotechnological production of sec ondary compounds an extremely complicated task.
Classification of secondary metabolites may be based on the chemical structure or biological charac teristics of substances. In general, three big groups of secondary compounds can be assigned: terpenes, phe nolics and alkaloids, which include the main part of currently identified compounds. Their number is esti mated to be from more than 50 000 structures to about 100 000 [2, [14] [15] [16] .
Many terpenes exhibit strong pharmacological activities against a number of human diseases. Among them we can mention cardenolides of Digitalis sp. [17] , glycyrrhizin extracted from the licorice root and calanolides from Calophyllum with anti HIV activities [18] , antibacterial shikonin from Lithospermum eryth rorhizon [19] , monoterpenoid alkaloid camptothecin isolated from Camptotheca acuminate and Nothapodytes foetida [20, 21] , artemisinin from Artemisia annua used for malaria treatment and having additionally cyto toxic features [22, 23] , and many others. In recent publications Morimoto et al. reported about success ful studies of cannabinoid biosynthesis: 5 enzymes were characterized and the corresponding genes were cloned [24, 25] . Heterologous expression of tetrahy drocannabinolic acid synthase gene resulted in forma tion of tetrahydrocannabinolic acid (precursor of tet rahydrocannabinol) from cannabigerolic acid [24] . This gene was later expressed in Pichia pastoris cells. High level of enzymatic activity (app. 1.3 nkat/L) was detected in culture medium [26] .
In spite of impressive scope and wide range of researches, only several secondary biosynthetic path ways have been studied in details on the enzymatic and gene levels. In our manuscript we will focus on these examples. Evidently, the frame of this publication does not allow performing a thorough review of all plant secondary metabolism research areas. Therefore we will discuss here biotechnological systems developed for production of certain valuable and perspective nat ural products.
Artemisinin production. Artemisinin from A. annua is currently one of the most effective antimalarial drugs recommended by WHO during short course artemisi nin based combination therapy [27] . Low content of artemisinin in plants (0.01-1% DW) and ever growing demand for artemisinin containing pharmaceuticals stimulated studies on biosynthetic pathway of this com pound formation and attempts to enhance its accumu lation in plant systems [28] . Total organic synthesis of artemisinin was found to be very difficult and costly process [29] . More perspective were approaches on improvement of artemisinin production in plant tissue under salinity stress conditions [30] .
Numerous studies have been carried out in order to obtain artemisinin from plant cell culture systems by selection of a highly productive line, supplying with precursors or elicitation [28, 31] . Additionally a hairy root culture of A. annua was established [32] .
Cloning of several terpene biosynthesis genes like cotton farnesyl diphosphate synthase and its overex pression in A. annua hairy roots resulted in three to four fold higher yield of artemisinin [33] . Redirection of amorpha 4,11 diene synthase and farnesyl diphos phate synthase to the plastids in transgenic Nicotiana tabacum allowed to enhance considerably accumula tion of one of the artemisinin precursors, amorpha 4,11 diene [34] .
The most promising way to scale up the production of artemisinin was cloning and heterologous expres sion of genes coding for several consequent enzymes of mevalonate pathway (amorpha 4,11 diene synthase, cytochrome P450 monooxygenase (CYP71AV1), cytochrome P450 oxidoreductase) from A. annua in Saccharomyces cerevisiae strain (Fig. 1 ). As a result, 100 mg/L of artemisinic acid, direct precursor of arte misinin, were synthesized in the course of three step reaction from native yeast intermediate metabolite farnesyl pyrophosphate. Its further conversion to arte misinin is not complex [35, 36] . Production of arte misinic acid from S. cerevisiae in bioreactor increased recently 25 fold and reached up to 2.5 g/L [37] . This example demonstrates efficiency of the present strat egy of secondary pathway genetic engineering com prising characterization and cloning of respective genes, regulator elements and correct choice of heter ologous expression system. Paclitaxel production. Perhaps one of the most famous cytotoxic natural compounds discovered dur ing the last decades was diterpene amid paclitaxel also known as taxol. Its antitumour activity as a component of Taxus brevifolia extract is known since 1965; in 1972 the chemical structure of taxol was elucidated [38] . In 1992 Taxol ® was registered and appeared in the world pharmaceutical market. Numerous clinical trials proved its efficiency against several types of cancer currently making taxol one of the most perspective anticancer drugs. Cytotoxic effect of paclitaxel is SHELUDKO HO O H H based on cell division blocking by microtubules stabi lization [39, 40] . Ever growing demand for paclitaxel and its low content in wood of slowly growing yew trees (about 0.03% d. w. in T. brevifolia bark of several hundred thousands of yew trees needs to be extracted to supply world year demand for paclitaxel) stimulated researches on chemical and biotechnology synthesis of this compound. More than 300 relative compounds have been isolated and characterised from different Taxus species up to now [41] .
The total chemical synthesis of paclitaxel was found to be very complex process too expensive for commercial production. Partial biosynthesis of pacli taxel and its more active derivatives like Taxotere ® from precursors (for example, baccatin III) appeared more perspective. Baccatin III was isolated from yew needles that did not destroy trees and extended the source of raw materials [40, 42] .
High value of paclitaxel and its extremely low nat ural supply became a prerequisite for numerous projects on selection of highly productive Taxus cell lines and enhancing of paclitaxel biosynthesis in cell cultures. Results of these studies were summarized in recent publications [43, 44] . Manipulation with cul tural medium composition in combination with effi cient selection allowed in a number of cases accumu lation of paclitaxel in cells up to 0.03-0.05% d. w. that is comparable or even surpasses the metabolite level in T. brevifolia bark [45, 46] . Further investigation proved efficiency of elicitation for taxoid biosynthesis stimulation because a number of important enzymes of terpene pathway (for instance geranylgeranyl diphosphate synthase and taxadiene synthase) are jas monate inducible [47, 48] .
Tabata reported that development of Taxus cell sus pension selection, cultivation and elicitation protocol resulted in stable paclitaxel production up to 295 mg/L [49] . Multiple jasmonate treatments in bioreactor increased taxoid yield in cell suspensions up to 612 mg/L [50] . Companies of Phyton Catalytic Inc. (USA) and Samyang Genex (South Korea) informed about commercial isolation of paclitaxel from cell cul tures [16, 39] .
Two alternative pathways of terpene biosynthesis have been described at present time. Both pathways lead to production of common terpene precursors (dimeth ylallyl diphosphate (DMAPP) and isopentenyl diphos phate (IPP)) which can be transformed in more com plex molecules in the course of further conversions. The classic mevalonate pathway (MYA) which functions in the cytosol initially was assumed to be the sole source of the terpenoid precursors IPP and DMAPP. It supplies the precursors for production of sesquiterpenes and trit erpenes. Alternative pathway named after the first com mitted precursor, 2 C methyl D erythritol 4 phos phate (MEP) is localized in plastids and is generally used to supply precursors for the production of monot erpenoids, diterpenoids and tetraterpenoids [1, 51] . Moreover, recent studies showed possibilities for inter changes between intermediates of the both pathways [52] . Experiments on inhibition of IPP transport from cytoplasm to plastids demonstrated that some IPP from mevalonate pathway might be transfered from the cyto plasm to the plastids in the course of taxol and baccatin III biosynthesis. It was also presumed that different IPP biosynthesis pathways occur during different growth phases in Taxus cells [53] .
Because of diterpenoid origin of paclitaxel, the spe cial attention was paid to the investigation of MEP Vol. 44 No. 1 2010 RECENT ADVANCES IN PLANT BIOTECHNOLOGY AND GENETIC ENGINEERING 55 pathway regulation and cloning the appropriate genes. In general, 15 consequent secondary enzymatic reac tions should be accomplished to form baccatin III the key precursor of paclitaxel [54] (Fig. 2) . Recent reviews reported cloning and characterization of 10 genes of taxane biosynthesis [43, 51 and references cited therein, 54, 55]. In particular, 2 C methyl D erythritol 2,4 cyclodiphosphate synthase gene, which is the 5 th enzyme of the MEP pathway, was cloned from T. medium [56] . The efficiency of Agrobacterium transformation of yew cells is low and successful transformation protocol of Taxus cell suspensions was developed not long ago [57] . Because of this the majority of cloned genes were functionally expressed in E. coli and Saccharomyces cerevisiae [54, 58] . In the last case, 5 genes coding for 5 consequent reaction enzymes from primary metabo lism to the intermediate taxadien 5 α acetoxy 10 β ol were installed in a single yeast host. It was shown that enzymes encoded by introduced heterologous genes utilized yeast isoprenoid precursors. However biosyn thesis was blocked at the first cytochrome P450 hydroxylation step [54] . In order to enhance the hydroxylation activity, coexpression of cytochrome P450 reductase with cytochrome P450 oxygenase was successfully performed in yeast cells [59] .
Among plant species, A. thaliana was transformed with recombinant T. baccata taxadiene synthase gene coding for plastid localized enzyme of one of early stages of paclitaxel biosynthesis catalyzing conversion of geranylgeranyl diphosphate to taxadiene. It led to accumulation of taxadiene in Arabidopsis cells [60] . This experiment demonstrated the perspective of approaches based on engaging of natural terpenoid precursors of plant host in taxane biosynthesis payth way. However, constitutive production of the full length His tagged enzyme in A. thaliana plants caused growth retardation and decreased the levels of photo synthetic pigments. Although these effects may be driven by a toxic taxadiene, the lower accumulation of endogenous plastid isoprenoids such as carotenoids and chlorophylls in transgenic plants also suggested the alteration of the balance of geranylgeranyl diphos phate pool. Using of inducible transgene expression system allowed optimization of taxadiene production which reached 30 fold higher levels than those in plants constitutively expressing the transgene [60] , Even higher taxadiene accumulation was observed after expression of taxadiene synthase in tomato fruits due to redirection of carotenoid metabolites: about 160 mg of taxadiene was extracted from 1 kg of freeze dried fruits [61] .
Except for higher plants, taxadiene synthase was expressed in a moss Physcomitrella patens [62] and in the yeast S. cerevisiae [63] . Transgenic moss accumu lated taxadiene up to 0.05% of fresh weight. Transgene expression did not affect significantly the amounts of the endogenous diterpenoids. In contrast to other transgenic plants expressing heterologous taxadiene synthase, transgenic P. patens did not exhibit any growth inhibition due to the alteration of diterpenoid metabolic pools that suggests the perspective of this object for the biotechnological production of pacli taxel and its precursors.
Introduction of T. chinensis taxadiene synthase alone in S. cerevisiae did not increase the taxadiene levels because of insufficient levels of the universal diterpenoid precursor geranylgeranyl diphosphate. In order to attain a high level of taxadiene and its inter mediate metabolites, geranylgeranyl diphosphate syn thase from Sulfolobus acidocaldarius and codon opti mized T. chinensis taxadiene synthase gene were intro duced into yeast genome. It resulted in 40 fold increase in taxadiene to app. 8.7 mg/L as well as signif icant amounts of geranyl geraniol (app. 33.1 mg/L), suggesting possibility for further increase of taxadiene level [63] . Scopolamine production. The anticholinergic tro pane alkaloids hyosciamine, its racemic form atro pine, and scopolamine have been known among the oldest drugs in the medicine because of their effect on parasympathetic nervous system. Currently they are widely used in pharmacology as muscle relaxants. These substances together with a number of other tro pane alkaloids were isolated mainly from Solanaceae species, although tropane alkaloids were additionally detected in plants of several other families [64] . Hyos cyamine is normally the more abundant alkaloid in Solanacea species while scopolamine (which is more physiologically active and valuable) is produced in greater quantities only in Duboisia spp and Datura metel [64, 65] . As it was also shown for other natural products mentioned above, the chemical synthesis of these alkaloids has proved to be difficult and not eco nomically feasible so that plant material is their only source. World demand for scopolamine was estimated to be about 10 times greater than that of hyoscyamine together with atropine [66] . This provoked the interest to tropane alkaloid biosynthesis pathway and biotech nological production of scopolamine. Because it was shown that undifferentiated systems such as calluses or cell cultures have low productivity [67] , hairy roots caused by the infection of plants with A. rhizogenes have been chosen as an object for attempts to enhance scopolamine production. Owing to their stable and high productivity, hairy root cultures have been inves tigated for several decades for biotechnological pro duction of the valuable metabolites (progress in under standing of secondary biosynthesis mechanisms in hairy root cultures was reflected in the recent reviews [68] [69] [70] [71] .
Hairy roots of Hyoscyamus muticus may produce high contents of hyoscyamine, but in many cases only trace amounts of scopolamine [72] . Sevon et al.
described obtaining and analysis of hairy roots in more than 15 species. Amounts of scopolamine in the stud ied cultures varied from 0.2 to 32 mg/g DW Laborious selection of the more productive clones and optimiza tion of the growth conditions was often necessary to reach these levels of scopolamine accumulation [71] . Thus it is obvious that metabolic engineering of this biosynthetic pathway or its single steps could help to improve scopolamine production. In particular, the conversion of hyoscyamine to the much more valuable scopolamine could be regarded as the major goal of these studies.
Early stages of nicotine and tropane alkaloid bio synthesis are coinciding and discussed together with further reactions in the recent reviews [65, 73] . The first committed step of both pyridine and tropane alkaloid metabolism is S adenosylmethionine (SAM) dependent methylation of putrescine cataly sed by putrescine N methyltransferase, forming N methylputrescine.
The overexpression of N. tabacum putrescine N methyltransferase (PMT) gene in scopolamine rich Duboisia hybrids, Datura metel, Atropa belladonna and H. muticus caused increasing in accumulation of the direct metabolite N methylputrescine (2 4 fold compared to wild type roots) [74] , but there was no significant increase in either tropane or pyridine type alkaloids [74] [75] [76] or the effect on the alkaloid level was only marginal. However, regulation of the expression of this gene can be crucial for alkaloid production in several species: in some transgenic N. sylvestris lines overexpression of pmt gene increased the nicotine content, whereas sup pression of endogenous PMT activity severely decreased the nicotine content and induced abnormal morphologies [75] .
Scopolamine is 6,7β epoxide derivative of hyos cyamine, formed from hyoscyamine in a two step pro cess via 6β hydroxyhyoscyarnine [78] by enzyme hyoscyamine 6β hydroxylase (H6H) which can be classified as 2 oxoglutarate dependent dioxygenase (Fig. 3) . The enzyme was purified and characterized from H. niger [79] . The cDNA encoding H. niger H6H has been isolated by Matsuda et al. [80] . Additionally, H6H cDNA was cloned from several other scopola mine producing Solanaceae species e.g. A. baetica [81] , A. belladonna [82] , Anisodus tanguticus [83] etc. Additionally, tropinone reductase, which catalyzes an earlier reaction of scopolamine biosynthesis in H. niger, has been cloned [84] . H6H gene from H. niger was placed under the control of 35S promoter and introduced to A. belladonna using A. rhizogenes. The obtained hairy roots contained up to five fold higher concentrations of scopolamine than wild type cultures [85] . Hyoscyamine was almost completely converted to scopolamine in the leaves of transgenic A. belladonna plants expressing h6h gene. The level of scopolamine in the leaves reached up to 1.2% DW [86] . Later, 35S h6h gene was introduced into H. muti cus producing high amounts of tropane alkaloids Vol. 44 No. 1 2010 RECENT ADVANCES IN PLANT BIOTECHNOLOGY AND GENETIC ENGINEERING 57
(up to 6% of the dry weight in the leaves of mature plant). The best selected transgenic line produced 17 mg/L scopolamine, although conversion of hyos cyamine to scopolamine was still incomplete. In these examples overexpression of a single gene in the path way has often led to an improved accumulation of the more valuable end product.
Further experiments included simultaneous over expression of genes encoding PMT and the down stream H6H in H. niger hairy root cultures. It resulted in accumulation of significantly higher amounts of scopolamine (up to 411 mg/L,) in hairy root lines expressing both pmt and h6h genes compared with the control cultures (app. nine times more than that in the wild type) and transgenic lines harboring only one of the mentioned genes (more than two times higher level of scopolamine as compared with the best single gene transgenic lines) [87] .
Biotransformation was reported to be an alternative way for scopolamine production using non hyos cyamine producing transgenic systems fed with pre cursor hyoscyamine. Hairy roots of N. tabacum trans formed with 35S h6h gene have been studied for the production of scopolamine and nicotine alkaloids after feeding the cultures with hyoscyamine. In the optimal conditions the most productive clones of N. tabacum hairy roots converted up to 45% of exoge nous hyoscyamine to scopolamine; up to 85% of the total scopolamine was released to the culture medium [88] . Recently, the protocol for bioconversion of hyos cyamine into scopolamine in bioreactor with N. tabacum cell suspension cultures was reported [89] . Functionally active H6H was obtained after heterolo gous expression of h6h gene from Brugmansia candida in S. cerevisiae [90] .
Conclusions and future perspectives. In conclusion, cloning and heterologous overexpression of genes cod ing for several key enzymes of secondary metabolism often allowed considerable increasing of the level of valuable end product. The next step on the way to obtaining the commercial amounts of metabolite included correct choice of expression system and adaptation of the process to bioreactor scale. However, the efficient control of desired product synthesis requires a complete knowledge of all the steps in bio synthetic pathway, regulation mechanisms and clon ing of the respective genes. It is difficult to forecast the results of introduction into plant genome of a single or reduced number of genes. Their overexpression may cause appearance of multiple rate limiting steps and did not enhance production of desirable metabolite. It is necessary to consider the processes involved in the regulation of the whole pathway and interconnecting cellular pathways. Alternatively, translocation of gene cluster encoding the enzymes responsible for sequence of biochemical conversation in non plant expression system can result in creation of highly efficient pro ductive complex.
